医学
胰岛素抵抗
胰岛素
超重
有氧运动
内科学
内分泌学
肥胖
久坐的生活习惯
作者
Stephanie Kullmann,Thomas Goj,Ralf Veit,Louise Fritsche,Lore Wagner,Patrick Schneeweiss,Miriam Hoene,Christoph Hoffmann,Jürgen Machann,Andreas Niess,Hubert Preissl,Andreas L. Birkenfeld,Andreas Peter,Hans-Ulrich Häring,Andreas Fritsche,Anja Moller,Cora Weigert,Martin Heni
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2022-09-22
卷期号:7 (18)
标识
DOI:10.1172/jci.insight.161498
摘要
BACKGROUNDInsulin resistance of the brain can unfavorably affect long-term weight maintenance and body fat distribution. Little is known if and how brain insulin sensitivity can be restored in humans. We aimed to evaluate the effects of an exercise intervention on insulin sensitivity of the brain and how this relates to exercise-induced changes in whole-body metabolism and behavior.METHODSIn this clinical trial, sedentary participants who were overweight and obese underwent an 8-week supervised aerobic training intervention. Brain insulin sensitivity was assessed in 21 participants (14 women, 7 men; age range 21-59 years; BMI range 27.5-45.5 kg/m2) using functional MRI, combined with intranasal administration of insulin, before and after the intervention.RESULTSThe exercise program resulted in enhanced brain insulin action to the level of a person of healthy weight, demonstrated by increased insulin-induced striatal activity and strengthened hippocampal functional connectivity. Improved brain insulin action correlated with increased mitochondrial respiration in skeletal muscle, reductions in visceral fat and hunger, as well as improved cognition. Mediation analyses suggest that improved brain insulin responsiveness helps mediate the peripheral exercise effects leading to healthier body fat distribution and reduced perception of hunger.CONCLUSIONOur study demonstrates that an 8-week exercise intervention in sedentary individuals can restore insulin action in the brain. Hence, the ameliorating benefits of exercise toward brain insulin resistance may provide an objective therapeutic target in humans in the challenge to reduce diabetes risk factors.TRIAL REGISTRATIONClinicalTrials.gov (NCT03151590).FUNDINGBMBF/DZD 01GI0925.
科研通智能强力驱动
Strongly Powered by AbleSci AI